Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts

Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook
  • Major roles of the circadian clock in cancer
  • Metabolic regulation of immune responses to cancer
  • Glycolytic potential enhanced by blockade of pyruvate influx into mitochondria sensitizes prostate cancer to detection and radiotherapy
  • Strategies to enhance monoclonal antibody uptake and distribution in solid tumors
  • Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis
  • 1
  • 2
  • 3
  • 4
  • 5

Latest Articles

  • You have access
    Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
    Lingxiang Wu, Ruichao Chai, Zihan Lin, Rongrong Wu, Diru Yao, Tao Jiang and Qianghu Wang
    Cancer Biology & Medicine March 2023, 20220771; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0771
  • You have access
    Understanding the mechanisms underlying obesity in remodeling the breast tumor immune microenvironment: from the perspective of inflammation
    Hengjun Zhang, Mozhi Wang and Yingying Xu
    Cancer Biology & Medicine March 2023, 20220547; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0547
  • You have access
    Cancer risk in relatives of BRCA1/2 pathogenic variant carriers in a large series of unselected patients with breast cancer
    Jiaming Liu, Lu Yao, Jie Sun, Li Hu, Jiuan Chen, Juan Zhang, Ye Xu and Yuntao Xie
    Cancer Biology & Medicine February 2023, 20 (2) 147-154; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0593
  • You have access
    Conceptualizing the complexity of ferroptosis to treat triple-negative breast cancer: theory-to-practice
    Hang Zhang, Fan Yang, Yi Xiao, Yi-Zhou Jiang and Zhi-Ming Shao
    Cancer Biology & Medicine February 2023, 20 (2) 98-103; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0767
  • You have access
    Intercellular transmission of cGAS-STING signaling in cancer
    Qirou Wu, Xiaohong Leng and Pinglong Xu
    Cancer Biology & Medicine February 2023, 20 (2) 93-97; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0750
  • You have access
    2022 Chinese expert consensus and guidelines on clinical management of toxicity in anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
    Ping Li, Yang Liu, Yun Liang, Jian Bo, Sujun Gao, Yongxian Hu, Yu Hu, He Huang, Xiaojun Huang, Hongmei Jing, Xiaoyan Ke, Jianyong Li, Yuhua Li, Qifa Liu, Peihua Lu, Heng Mei, Ting Niu, Yongping Song, Yuqin Song, Liping Su, Sanfang Tu, Jianxiang Wang, Depei Wu, Zhao Wang, Kailin Xu, Zhitao Ying, Qingming Yang, Yajing Zhang, Fengxia Shi, Bin Zhang, Huilai Zhang, Xi Zhang, Mingfeng Zhao, Weili Zhao, Xiangyu Zhao, Liang Huang, Jun Zhu, Wenbin Qian, Weidong Han and Aibin Liang
    Cancer Biology & Medicine February 2023, 20 (2) 129-146; DOI: https://doi.org/10.20892/j.issn.2095-3941.2022.0585
View more latest articles

Cover Story

Current issue

Cancer Biology & Medicine: 20 (2)
Cancer Biology & Medicine
Vol. 20, Issue 2
15 Feb 2023
  • Table of Contents
  • Index by author

Submit

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives
Back to top

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2023 Cancer Biology & Medicine

Powered by HighWire